Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Misoprostol | hsa00561 | Glycerolipid metabolism | 2.51E-02 | 2 | P51648, P23743 | ALDH3A2, DGKA | More | | Misoprostol | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | | Misoprostol | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | | Misoprostol | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.78E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Misoprostol | hsa01100 | Metabolic pathways | 4.12E-02 | 12 | P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, P40925, P23743, P43034, P09917, Q53FZ2 | GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, MDH1, DGKA, PAFAH1B1, ALOX5, ACSM3 | More | | Misoprostol | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | | Misoprostol | hsa04012 | ErbB signaling pathway | 9.49E-03 | 3 | Q92529, P19174, P42338 | SHC3, PLCG1, PIK3CB | More | | Misoprostol | hsa04014 | Ras signaling pathway | 2.29E-04 | 7 | P42338, Q92529, Q9NRA1, P49767, P63218, P50151, P19174 | PIK3CB, SHC3, PDGFC, VEGFC, GNG5, GNG10, PLCG1 | More | | Misoprostol | hsa04015 | Rap1 signaling pathway | 3.91E-02 | 4 | Q9NRA1, P49767, P42338, P19174 | PDGFC, VEGFC, PIK3CB, PLCG1 | More | | Misoprostol | hsa04020 | Calcium signaling pathway | 2.16E-02 | 4 | P27987, P19174, Q9NRA1, P49767 | ITPKB, PLCG1, PDGFC, VEGFC | More | | Misoprostol | hsa04062 | Chemokine signaling pathway | 4.35E-03 | 6 | P07948, P42338, P19174, Q92529, P63218, P50151 | LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10 | More | | Misoprostol | hsa04070 | Phosphatidylinositol signaling system | 3.19E-04 | 5 | P19174, P42338, P23743, Q96PE3, P27987 | PLCG1, PIK3CB, DGKA, INPP4A, ITPKB | More | | Misoprostol | hsa04072 | Phospholipase D signaling pathway | 1.85E-04 | 6 | P42338, Q92529, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, SHC3, PLCG1, GNA13, DGKA, PDGFC | More | | Misoprostol | hsa04151 | PI3K-Akt signaling pathway | 2.55E-03 | 8 | P42338, Q9NRA1, P49767, P08238, P63218, P50151, O15335, P14784 | PIK3CB, PDGFC, VEGFC, HSP90AB1, GNG5, GNG10, CHAD, IL2RB | More | | Misoprostol | hsa04370 | VEGF signaling pathway | 1.56E-02 | 2 | P19174, P42338 | PLCG1, PIK3CB | More | | Misoprostol | hsa04371 | Apelin signaling pathway | 1.24E-02 | 4 | P63218, P50151, Q13370, Q14344 | GNG5, GNG10, PDE3B, GNA13 | More | | Misoprostol | hsa04510 | Focal adhesion | 1.55E-02 | 5 | P42338, O15335, Q9NRA1, P49767, Q92529 | PIK3CB, CHAD, PDGFC, VEGFC, SHC3 | More | | Misoprostol | hsa04611 | Platelet activation | 4.11E-02 | 3 | P42338, Q14344, P07948 | PIK3CB, GNA13, LYN | More | | Misoprostol | hsa04658 | Th1 and Th2 cell differentiation | 1.01E-02 | 4 | P07766, P19174, P14784, Q13761 | CD3E, PLCG1, IL2RB, RUNX3 | More | | Misoprostol | hsa04659 | Th17 cell differentiation | 2.16E-02 | 4 | P19174, P14784, P08238, P07766 | PLCG1, IL2RB, HSP90AB1, CD3E | More | | Misoprostol | hsa04662 | B cell receptor signaling pathway | 2.78E-02 | 3 | P42338, P07948, Q8N149 | PIK3CB, LYN, LILRA2 | More | | Misoprostol | hsa04664 | Fc epsilon RI signaling pathway | 7.30E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Misoprostol | hsa04666 | Fc gamma R-mediated phagocytosis | 1.73E-02 | 3 | P07948, P42338, P19174 | LYN, PIK3CB, PLCG1 | More | | Misoprostol | hsa04722 | Neurotrophin signaling pathway | 4.87E-02 | 3 | P42338, P19174, Q92529 | PIK3CB, PLCG1, SHC3 | More | | Misoprostol | hsa04724 | Glutamatergic synapse | 1.73E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Misoprostol | hsa04725 | Cholinergic synapse | 1.73E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Misoprostol | hsa04726 | Serotonergic synapse | 3.41E-02 | 3 | P63218, P50151, P09917 | GNG5, GNG10, ALOX5 | More | | Misoprostol | hsa04727 | GABAergic synapse | 6.57E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Misoprostol | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Misoprostol | hsa04910 | Insulin signaling pathway | 4.11E-02 | 3 | Q92529, Q13370, P42338 | SHC3, PDE3B, PIK3CB | More | | Misoprostol | hsa04914 | Progesterone-mediated oocyte maturation | 2.22E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Misoprostol | hsa04915 | Estrogen signaling pathway | 4.76E-03 | 4 | P42338, Q92529, P08238, P11142 | PIK3CB, SHC3, HSP90AB1, HSPA8 | More | | Misoprostol | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | | Misoprostol | hsa04926 | Relaxin signaling pathway | 1.31E-03 | 5 | P42338, P63218, P50151, P49767, Q92529 | PIK3CB, GNG5, GNG10, VEGFC, SHC3 | More | | Misoprostol | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 4.11E-02 | 3 | P42338, P49767, P19174 | PIK3CB, VEGFC, PLCG1 | More | | Misoprostol | hsa04935 | Growth hormone synthesis, secretion and action | 2.78E-02 | 3 | P19174, P42338, Q92529 | PLCG1, PIK3CB, SHC3 | More | | Misoprostol | hsa05032 | Morphine addiction | 2.22E-02 | 3 | P63218, P50151, Q13370 | GNG5, GNG10, PDE3B | More | | Misoprostol | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | | Misoprostol | hsa05162 | Measles | 3.91E-02 | 4 | P14784, P07766, P42338, P11142 | IL2RB, CD3E, PIK3CB, HSPA8 | More | | Misoprostol | hsa05163 | Human cytomegalovirus infection | 1.14E-02 | 5 | P42338, P63218, P50151, Q14344, P30101 | PIK3CB, GNG5, GNG10, GNA13, PDIA3 | More | | Misoprostol | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.14E-02 | 5 | P42338, P63218, P50151, P19174, P07948 | PIK3CB, GNG5, GNG10, PLCG1, LYN | More | | Misoprostol | hsa05169 | Epstein-Barr virus infection | 3.34E-02 | 5 | P42338, P07948, P30101, Q13761, P07766 | PIK3CB, LYN, PDIA3, RUNX3, CD3E | More | | Misoprostol | hsa05170 | Human immunodeficiency virus 1 infection | 7.03E-03 | 6 | P42338, P63218, P50151, P30101, P19174, P07766 | PIK3CB, GNG5, GNG10, PDIA3, PLCG1, CD3E | More | | Misoprostol | hsa05200 | Pathways in cancer | 3.05E-02 | 8 | P42338, P08238, P19174, P49767, P63218, P50151, Q14344, P14784 | PIK3CB, HSP90AB1, PLCG1, VEGFC, GNG5, GNG10, GNA13, IL2RB | More | | Misoprostol | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | | Misoprostol | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | | Misoprostol | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | | Misoprostol | hsa05231 | Choline metabolism in cancer | 1.17E-03 | 4 | P42338, Q9NRA1, P19174, P23743 | PIK3CB, PDGFC, PLCG1, DGKA | More | | |